Gavin Churchyard

20.6k total citations
282 papers, 10.3k citations indexed

About

Gavin Churchyard is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Gavin Churchyard has authored 282 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Infectious Diseases, 173 papers in Epidemiology and 63 papers in Surgery. Recurrent topics in Gavin Churchyard's work include Tuberculosis Research and Epidemiology (182 papers), Pneumocystis jirovecii pneumonia detection and treatment (89 papers) and HIV/AIDS Research and Interventions (64 papers). Gavin Churchyard is often cited by papers focused on Tuberculosis Research and Epidemiology (182 papers), Pneumocystis jirovecii pneumonia detection and treatment (89 papers) and HIV/AIDS Research and Interventions (64 papers). Gavin Churchyard collaborates with scholars based in South Africa, United Kingdom and United States. Gavin Churchyard's co-authors include Alison D. Grant, Katherine Fielding, Salome Charalambous, Elizabeth L. Corbett, Kevin M. De Cock, Stephen D Lawn, Richard Hayes, Richard E. Chaisson, Violet Chihota and Salim S. Abdool Karim and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Gavin Churchyard

270 papers receiving 10.0k citations

Peers

Countries citing papers authored by Gavin Churchyard

Since Specialization

Citations

This map shows the geographic impact of Gavin Churchyard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Churchyard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Churchyard more than expected).

Fields of papers citing papers by Gavin Churchyard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Churchyard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Churchyard. The network helps show where Gavin Churchyard may publish in the future.

Co-authorship network of co-authors of Gavin Churchyard

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Churchyard. A scholar is included among the top collaborators of Gavin Churchyard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Churchyard. Gavin Churchyard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights on the implementation strategies for a potential new tuberculosis vaccine in South Africa 2026 ·PLOS Global Public Health ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gavin Churchyard, (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection 2025 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Salome Charalambous, (unknown), (unknown), (unknown), Norbert Heinrich, Elin M. Svensson, Fareed Abdullah, Gavin Churchyard, Robert S. Wallis	0
3	Improving access to tuberculosis preventive treatment for children in Ethiopia: designing a home-based contact management intervention for the CHIP-TB trial through formative research 2024 ·BMC Health Services Research ·Nicole Salazar‐Austin, (unknown), Christiaan Mulder, Carrie Tudor, (unknown), (unknown), Richard E. Chaisson, Jonathan E. Golub, Gavin Churchyard, Ahmed Bedru, Deanna Kerrigan	1
4	Implications of subclinical tuberculosis for vaccine trial design and global effect 2024 ·The Lancet Microbe ·Gavin Churchyard, Rein M G J Houben, Katherine Fielding, (unknown), (unknown), (unknown), Molebogeng X. Rangaka, Marcel A. Behr, Alberto L Garcia-Basteiro, (unknown), Mark Hatherill, Vidya Mave, Alemnew F. Dagnew, (unknown), (unknown), (unknown), (unknown)	9
5	Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis 2023 ·The Journal of Infectious Diseases ·Pholo Maenetje, (unknown), Diana B. Schramm, (unknown), Robert S. Wallis, Mandla Mlotshwa, Caroline T. Tiemessen, Yun Li, Hardy Kornfeld, Gavin Churchyard, Sara C. Auld, Gregory P. Bisson	1
6	High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus 2023 ·Antimicrobial Agents and Chemotherapy ·(unknown), Yuri van der Heijden, Matthew S. Shotwell, Violet Chihota, Mark A. Marzinke, Richard E. Chaisson, Kelly E. Dooley, Gavin Churchyard	2
7	End-point definition and trial design to advance tuberculosis vaccine development 2022 ·European Respiratory Review ·Alberto L. García‐Basteiro, Richard G. White, Dereck Tait, Alexander C. Schmidt, Molebogeng X. Rangaka, Matthew Quaife, Elisa Nemes, (unknown), Philip C. Hill, Rebecca C. Harris, Willem A. Hanekom, Mike Frick, Andrew Fioré-Gartland, Tom Evans, Alemnew F. Dagnew, Gavin Churchyard, Frank Cobelens, Marcel A. Behr, Mark Hatherill	12
8	Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR 2022 ·SHILAP Revista de lepidopterología ·Simon C. Mendelsohn, Stanley Kimbung Mbandi, Andrew Fioré-Gartland, Adam Penn‐Nicholson, Munyaradzi Musvosvi, Humphrey Mulenga, Michelle Fisher, Katie Hadley, Mzwandile Erasmus, (unknown), Michèle Tameris, Gerhard Walzl, Kogieleum Naidoo, Gavin Churchyard, Mark Hatherill, Thomas J. Scriba	20
9	Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end TB 2019 ·PLoS Medicine ·Gavin Churchyard, (unknown)	24
10	Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis 2019 ·The Journal of Infectious Diseases ·Samuel G. Schumacher, William A. Wells, Mark P. Nicol, Karen R Steingart, Grant Theron, Susan E. Dorman, Madhukar Pai, Gavin Churchyard, Lesley Scott, Wendy Stevens, Pamela Nabeta, David Alland, Karin Weyer, Claudia M. Denkinger, Christopher Gilpin	20
11	Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa 2019 ·PLoS ONE ·Piotr Hippner, Tom Sumner, Rein M G J Houben, Vicky Cárdenas, Anna Vassall, Fiammetta Bozzani, (unknown), Lindiwe Mvusi, Gavin Churchyard, Richard G. White	9
12	Performance of verbal autopsy methods in estimating HIV-associated mortality among adults in South Africa 2018 ·BMJ Global Health ·Aaron S Karat, (unknown), Mpho Tlali, Salome Charalambous, Violet Chihota, Gavin Churchyard, Katherine Fielding, Yasmeen Hanifa, Suzanne M. Johnson, Kerrigan McCarthy, Kathleen Kahn, Daniel Chandramohan, Alison D. Grant	7
13	An intervention to optimise the delivery of integrated tuberculosis and HIV services at primary care clinics: results of the MERGE cluster randomised trial 2018 ·Contemporary Clinical Trials ·Tendesayi Kufa, Katherine Fielding, Piotr Hippner, Karina Kielmann, Anna Vassall, Gavin Churchyard, Alison D. Grant, Salome Charalambous	10
14	Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention 2017 ·Tuberculosis ·Andrew Fioré-Gartland, Lindsay N. Carpp, Kogieleum Naidoo, Ethan Thompson, Daniel E. Zak, Steve Self, Gavin Churchyard, Gerhard Walzl, Adam Penn‐Nicholson, Thomas J. Scriba, Mark Hatherill	19
15	Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model 2017 ·PLoS Medicine ·Emily A. Kendall, Sourya Shrestha, Ted Cohen, Eric L. Nuermberger, Kelly E. Dooley, Licé González-Angulo, Gavin Churchyard, Payam Nahid, Michael Rich, (unknown), (unknown), Christian Lienhardt, David W. Dowdy	19
16	Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data 2017 ·PLoS ONE ·Aaron S Karat, Mpho Tlali, Katherine Fielding, Salome Charalambous, Violet Chihota, Gavin Churchyard, Yasmeen Hanifa, Suzanne M. Johnson, Kerrigan McCarthy, Neil Martinson, Tanvier Omar, Kathleen Kahn, Daniel Chandramohan, Alison D. Grant	23
17	Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa 2016 ·PLoS ONE ·Aaron S Karat, Tanvier Omar, Anne von Gottberg, Mpho Tlali, Violet Chihota, Gavin Churchyard, Katherine Fielding, Suzanne M. Johnson, Neil Martinson, Kerrigan McCarthy, Nicole Wolter, Emily Wong, Salome Charalambous, Alison D. Grant	44
18	Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. 2006 ·PubMed ·(unknown), Salome Charalambous, Katherine Fielding, Richard Hayes, Gavin Churchyard, Alfred D. Grant	64
19	Human Immunodeficiency Virus and the Prevalence of Undiagnosed Tuberculosis in African Gold Miners 2004 ·American Journal of Respiratory and Critical Care Medicine ·Elizabeth L. Corbett, Salome Charalambous, (unknown), Katherine Fielding, Alison D. Grant, Christopher Dye, Kevin M. De Cock, Richard Hayes, Brian Williams, Gavin Churchyard	139
20	Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. 1999 ·PubMed ·Elizabeth L. Corbett, Margaret Hay, Gavin Churchyard, (unknown), Tim Clayton, Brian Williams, Richard Hayes, Daan Mulder, Kevin M. De Cock	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact